2025 Volume 41 Issue 1 Pages 21-26
Background: Since 2015, our hospital has been performing robot-assisted laparoscopic para-aortic lymphadenectomy for stage IA endometrial adenocarcinoma G3 and highly malignant histological types, as well as stages IB and II. In this study, we compared safety of robot-assisted surgery with laparoscopic and open surgery.
Methods: We retrospectively reviewed 49 cases of patients who underwent para-aortic lymphadenectomy for endometrial cancer between April 2016 and March 2024.
Results: For robot-assisted surgery, laparoscopic surgery, and open surgery, respectively, the median age and BMI were 56 years (range 43-69 years) and 21.8 (range 17.8-32.7), 54 years (range 28-68 years) and 22.9 (range 14.5-32.1), and 58 years (range 34-72 years) and 21.7 (range 15.3-24.6); the median operative time, blood loss, and number of lymph nodes removed were 264 minutes (range 213-326 minutes), 10 mL (range 10-50 mL), and 40 nodes (range 18-76 nodes), 297 minutes (range 288-366 minutes), 96 mL (range 10-400 mL), and 46 nodes (range 23-76 nodes), and 229 minutes (range 123-454 minutes), 833.5 mL (range 256-2,367 mL), and 34 nodes (range 11-54 nodes); the postoperative hospital stay was 4 days (range 3-7 days), 4 days, and 7 days (range 5-18 days). Intraoperative complications occurred in 1 case of laparoscopic surgery, while postoperative complications were seen in 5 cases of robot assisted surgery and 5 cases of open surgery.
Conclusion: Robot-assisted para-aortic lymphadenectomy for stage IA endometrial adenocarcinoma G3 and highly malignant histological types, as well as stages IB and II, appears to be a superior surgical technique in terms of surgical outcomes and safety compared to conventional methods.
